Please login to the form below

Not currently logged in
Email:
Password:

Gemzar

This page shows the latest Gemzar news and features for those working in and with pharma, biotech and healthcare.

Shire wins EU licence for pancreatic cancer drug Onivyde

Shire wins EU licence for pancreatic cancer drug Onivyde

following treatment with Lilly's Gemzar (gemcitabine). ... Celgene's Abraxane (paclitaxel) in combination with Gemzar.

Latest news

More from news
Approximately 2 fully matching, plus 21 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...

Infographics